BLFS
BioLife Solutions Inc
NASDAQ: BLFS · HEALTHCARE · MEDICAL INSTRUMENTS & SUPPLIES
$38.61
+0.00% today
Updated 2026-10-19
Market cap
$1.89B
P/E ratio
39.00
P/S ratio
17.71x
EPS (TTM)
$0.99
Dividend yield
—
52W range
$18 – $40
Volume
1.0M
BioLife Solutions Inc (BLFS) Financial Forecast & Price Target 2030
Revenue-driven projection model with historical context.
Price target summary
Current price
$38.61
12-Month target
—
2030 Target
—
Intrinsic (DCF)
$21.68
Financial forecast
| Metric | 2021 | 2022 | 2023 | 2024 | 2025 | 2027 (E) | 2028 (E) | 2029 (E) | 2030 (E) |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | $0.1B | $0.1B | $0.1B | $0.1B | $0.1B | $0.1B | $0.1B | $0.1B | $0.2B |
| EPS | — | — | — | — | — | — | — | — | — |
CAGR applied: 14.88% (capped 20%) · P/E: 25.00x (capped 25x) · Margin: 54.30%
Methodology
CAGR-based projection model. Research-backed estimates are being generated — check back soon for analyst consensus and management guidance.